APA (7th ed.) Citation

S, H., S, B., T, K., M, P., F, B., K, K., . . . RA, B. (2026). [68Ga]Ga-NECT-224 PET/CT Shows Increasing Nectin-4 Expression in Progressive Urothelial Carcinoma Under ADC-Therapy With Enfortumab-Vedotin. Clinical nuclear medicine. https://doi.org/10.1097/RLU.0000000000006528

Chicago Style (17th ed.) Citation

S, Hoberück, Banek S, Krönke T, Pretze M, Brandt F, Kopka K, Trommer J, Thomas C, and Bundschuh RA. "[68Ga]Ga-NECT-224 PET/CT Shows Increasing Nectin-4 Expression in Progressive Urothelial Carcinoma Under ADC-Therapy With Enfortumab-Vedotin." Clinical Nuclear Medicine 2026. https://doi.org/10.1097/RLU.0000000000006528.

MLA (9th ed.) Citation

S, Hoberück, et al. "[68Ga]Ga-NECT-224 PET/CT Shows Increasing Nectin-4 Expression in Progressive Urothelial Carcinoma Under ADC-Therapy With Enfortumab-Vedotin." Clinical Nuclear Medicine, 2026, https://doi.org/10.1097/RLU.0000000000006528.